Found 8 matching trials
A Study of Safety and Tolerability of Multiple Doses of HRS-7535 in Obese Subjects
PHASE1The study is being conducted to evaluate the safety, tolerability, pharmaco...
Location
Peking University Peoples Hospital
A Study of HRS-7535 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Diet and Exercise
PHASE3The aim of this trial is to evaluate the efficacy and safety of HRS-7535 co...
Location
Peking Union Medical College Hospital
Efficacy and Safety of HRS-7535 Tablets in Obese Subjects .
PHASE2The aim of this trial is to evaluate the efficacy and safety of HRS-7535 in...
Location
The First Medical Center of Chinese People's Liberation Army (PLA) General Hospital
A Trial of HRS-7535 Tablets in Subjects With Overweight or Obesity
PHASE3The study is being conducted to evaluate the efficacy and safety of HRS-753...
Location
Chinese PLA General Hospital
Efficacy and Safety of HRS-7535 Tablets in T2DM Subjects Poorly Controlled With Metformin and SGLT2i.
PHASE22 weeks screening period, 3 weeks run-in period, 16 weeks double-blind trea...
Location
The Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Study on the Efficacy and Safety of HRS-7535 in Patients With Mild Decrease in Ejection Fraction/Preserved Ejection Fraction Heart Failure and Obesity
PHASE2This is a multicenter, randomized, double-blind, placebo-controlled, parall...
Location
Fuwai Hospital, Chinese Academy of Medical Sciences
Efficacy and Safety of HRS-7535 Tablets in Adults With Diabetic Kidney Disease in Type 2 Diabetes
PHASE2The study is a 16-week multicenter, randomized, double-blind, placebo-contr...
Location
The First Affiliated Hospital, College of Medicine, Zhejiang University
Renal Efficacy and Safety of the Novel Oral Small-Molecule GLP-1RA HRS-7535 Evaluated in Participants With Chronic Kidney Disease
PHASE3This is a multicenter, randomized, double-blind, placebo-controlled, parall...
Location
Tianjin Medical University General Hospital